Comparative effect of Percutaneous Tibial Nerve Stimulation versus Transcutaneous Posterior Tibial Nerve Stimulation efficacy in the treatment of Overactive Bladder Syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016101730339N1

Enrollment

Registered

2016-12-04

Start date

2016-10-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder Syndrome. Other specified disorders of bladder Incl.: calcified, contracted or overactive Bladder

Interventions

Intervention 1: On the second group, Posterior Tibial Nerve Stimulation method is done with a surface pad electrod on the 5 cm to superior side of the medial Malleolus and posterior to tibia. The null

Treatment - Devices

On the second group, Posterior Tibial Nerve Stimulation method is done with a surface pad electrod on the 5 cm to superior side of the medial Malleolus and posterior to tibia. The null electrod is loc

In the first group, Posterior Tibial Nerve Stimulation method is done with a single gauge 34 filliform needle inserted on the 5 cm to superior side of the medial Malleolus and posterior to tibia. The

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Criteria for Overactive Bladder by American Urological Association 2014 Guideline: Each of these Items: Urgency: Sudden feeling of voiding that is irressitable; Frequency: Urination for more than 7 times during wakefulness; Nocturia: Waking for uriantion for more than 1 time; Incontinence: Sudden Involuntary Urine Leakage; Minimun of 18 years for age; Irrisponsiveness to Medical Therapy or Behavioral Change Therapies like Lifestyle Modification and Exercise Therapy; No Usge of Anticholinergic Medications Exclusion Criteria: Diabetes Mellitus; Pregnancy or Intention for that; Urinary Tract Infection or Recurrent Urinary Tract Infection (For more than 4 times a year); Pacemaker Device; Neurological Diseases; Lack of Cooperation or Follow Up

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Overactive Bladder Symptom. Timepoint: 0, 1 and 6 months after treatment. Method of measurement: Overactive Bladder Symtom Score.;Quality Of Life due to Incontinence. Timepoint: 0, 1 and 6 months after treatment. Method of measurement: Incontinence - Quality Of Life Questionnaire Items.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Esmail Nouri

Iran University of Medical Sciences (IUMS), Faculty of Medicine

drn94778@gmail.com, pghaboussi@yahoo.com+98 21 8214 1229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026